logo
Volume 8 - Pre-proof (Accepted manuscript)                   pbp 2026, 8 - Pre-proof (Accepted manuscript): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dawoud A, Aburizig M, Abbakar B, Ibrahim A, Fath Elrhman M, Aljaili O, et al . Herbal Cosmeceuticals in Sudan: Phytochemical Properties, Therapeutic Potentials, and Economic Opportunities. pbp 2026; 8
URL: http://pbp.medilam.ac.ir/article-1-350-en.html
1- 1. Assistant Professor of Pharmaceutics, at Medicinal & Aromatic Plants and Traditional Medicine Research Institute, National Centre for Research, Khartoum, Sudan.2. Pharmaceutical Department, Faculty of Pharmacy, National Ribat University, Sudan , azzadawoudhussien@gmail.com
2- Faculty of Pharmacy, National Ribat University, Sudan
Abstract:   (848 Views)
Objective: Herbal cosmeceuticals are gaining global attention due to their multifunctional, safe, and sustainable properties. Sudan, endowed with rich biodiversity and ethnobotanical heritage, hosts numerous medicinal plants traditionally used for skin and hair care. However, scientific validation, standardization, and industrial development of these plants remain limited. This review systematically identifies Sudanese medicinal plants with cosmeceutical potential, evaluates their phytochemical and pharmacological evidence, and explores industrial and economic opportunities.
Methods: A systematic search was conducted across PubMed, Scopus, Web of Science, ScienceDirect, Google Scholar, and AJOL up to August 2025. Boolean operators were used, and inclusion/exclusion criteria were applied following PRISMA guidelines. Study quality was assessed using CASP and AMSTAR 2 tools.
Results: Fifteen Sudanese medicinal plants were identified, with Nigella sativa, Lawsonia inermis, and Adansonia digitata being the most frequently studied. These plants exhibited antioxidant, anti-inflammatory, antimicrobial, moisturizing, and hair-strengthening effects. However, most evidence derived from in vitro and animal studies, with limited clinical validation and no standardized industrial formulations. SWOT analysis highlighted opportunities (biodiversity, global market demand, women’s empowerment) and challenges (regulatory gaps, limited infrastructure, lack of standardization).
Conclusion: Sudanese medicinal plants possess strong potential for developing innovative herbal cosmeceuticals. Future research should focus on clinical validation, standardization protocols, and industrial feasibility. Harnessing these resources could promote therapeutic innovation, empower local communities, and enhance Sudan’s role in the global “green beauty” market.

  
Full-Text [PDF 561 kb]   (115 Downloads)    
Type of Study: Review/Systemtic review | Subject: Herbal Drugs
Received: 2025/06/10 | Accepted: 2025/09/21 | Published: 2026/01/20

References
1. Amberg N, Fogarassy C. Green consumer behavior in the cosmetics market. Resources. 2019;8(3):137. https://doi.org/10.3390/resources8030137
2. Gediya SK, Mistry RB, Patel UK, Blessy M, Jain HN. Herbal plants: used as cosmetics. Pharmacognosy Reviews. 2011;5(9):82–95. https://doi.org/10.4103/0973-7847.79105
3. Kumar N, Mistry RB, Patel UK, et al. Herbal cosmetics: used for skin and hair. Pharmacognosy Journal. 2016;8(5):345–54. https://doi.org/10.5530/pj.2016.5.4
4. Hussain I, Ullah R, Ullah R, et al. Natural products in skin care: a review. Clinical Dermatology Review. 2022;6(2):65–71. https://doi.org/10.4103/cdr.cdr_11_22
5. Dureja H, Kaushik D, Gupta M, Kumar V, Lather V. Cosmeceuticals: an emerging concept. Indian J Pharmacol. 2005;37(3):155–9. https://doi.org/10.4103/0253-7613.16211
6. Lupo MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343–9. https://doi.org/10.1111/j.1529-8019.2007.00146.x
7. Sharmeen JB, Mahomoodally MF, Zengin G, Maggi F. Essential oils as natural sources of fragrance compounds for cosmetics and cosmeceuticals. Molecules. 2021;26(3):666. https://doi.org/10.3390/molecules26030666
8. Khalid H, Abdalla W, Abdelgadir H. Sudanese plants in ethnomedicine and cosmetics. J Ethnopharmacol. 2012;143(2):540–4. https://doi.org/10.1016/j.jep.2012.07.019
9. Hassaballa A, Ahmed A. Henna in Sudanese culture. Sudan J Tradit Med. 2022;6(1):45–51
10. Khider TO. The role of ethnobotany in Sudanese rural economy. Sudan J Econ Bot. 2018;12(4):233–40.
11. Sahebkar A, Iranshahy M, Afshari AR. Clinical evidence of medicinal plants in cosmeceuticals: current status and future perspectives. Phytother Res. 2019;33(11):2879–91. https://doi.org/10.1002/ptr.6459
12. Arora R, Kumar R, Sharma A. Regulatory frameworks for herbal cosmetics: current status and future perspectives. J Cosmet Dermatol. 2021;20(11):3735–42. https://doi.org/10.1111/jocd.14463
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
14. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. London: The Cochrane Collaboration; 2011. [No DOI]
15. Faccio M. Sustainable production in herbal cosmetics. Sustainability. 2020;12(4):1501. https://doi.org/10.3390/su12041501
16. Bitwell W, et al. Cosmeceuticals: bridging cosmetics and pharmaceuticals. Int J Pharm Sci. 2023;45(6):432–9.
17. Pandy A. Role of phytochemicals in cosmetics. Pharmacogn Rev. 2010;4(8):43–9. https://doi.org/10.4103/0973-7847.65324
18. Fowler JF, Woolery-Lloyd H, Waldorf H, Saini R. Innovations in natural ingredients for cosmeceuticals. J Drugs Dermatol. 2010;9(6 Suppl):s62–81.
19. European Commission. Horizon 2020: circular economy and natural cosmetics report. Brussels: EC; 2020.
20. Bouissan R, et al. Plant-derived cosmeceuticals: global trends. Nat Prod Commun. 2025;20(3):301–9.
21. Sahoo N, Manchikanti P, Dey S. Herbal drugs: standards and regulation. Fitoterapia. 2010;81(6):462–71. https://doi.org/10.1016/j.fitote.2010.02.001
22. Abdelwahab SI, Hassan LEA, Sirat HM. Anti-inflammatory activities of Lawsonia inermis Linn. J Med Plants Res. 2010;4(4):456–63.
23. Ali BH, Blunden G. Pharmacological and toxicological properties of Lawsonia inermis Linn. J Ethnopharmacol. 2003;83(1–2):19–23. https://doi.org/10.1016/S0378-8741(02)00299-6
24. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5(13–14):1749–70. https://doi.org/10.1016/j.intimp.2005.06.008
25. Ahmad A, Husain A, Mujeeb M, et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pac J Trop Biomed. 2013;3(5):337–52. https://doi.org/10.1016/S2221-1691(13)60075-1
26. Yagi A, El Tigani S. Evaluation of the biological activity of Aloe sinkatana from Sudan. Fitoterapia. 1998;69(5):409–12. https://doi.org/10.1016/S0367-326X(98)00067-3
27. Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules. 2008;13(8):1599–616. https://doi.org/10.3390/molecules13081599
28. Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa L.–a phytochemical and pharmacological review. Food Chem. 2014;165:424–43. https://doi.org/10.1016/j.foodchem.2014.05.002
29. De Caluwé E, Halamová K, Van Damme P. Adansonia digitata L. – a review of traditional uses, phytochemistry and pharmacology. Afr Focus. 2010;23(1):11–51. https://doi.org/10.21825/af.v23i1.5033
30. Chadare FJ, Linnemann AR, Hounhouigan JD, Nout MJR, Van Boekel MAJS. Baobab food products: a review on their composition and nutritional value. Crit Rev Food Sci Nutr. 2009;49(3):254–74. https://doi.org/10.1080/10408390701856330
31. Ismail A, Ikram EHK, Nazri HSM. Roselle (Hibiscus sabdariffa L.) seeds – nutritional composition, protein quality and health benefits. Food Chem. 2008;110(4):989–95. doi:10.1016/j.foodchem.2008.02.045
32. Shahat AA, Hammouda FM, Ismail SI, et al. Biologically active saponins from Balanites aegyptiaca Del. (Zygophyllaceae). Phytochem Rev. 2014;13(4):943–58. doi:10.1007/s11101-014-9358-9
33. Chothani DL, Vaghasiya HU. A review on Balanites aegyptiaca Del. (desert date): phytochemistry, pharmacological activities, and clinical evidence. Pharmacogn Rev. 2011;5(9):55–62. doi:10.4103/0973-7847.79101
34. Pathak N, Rai AK, Kumari R, Bhat KV. Value addition in sesame: a perspective on bioactive components for enhancing utility and profitability. Pharmacogn Rev. 2014;8(16):147–55. doi:10.4103/0973-7847.134229
35. Anilakumar KR, Pal A, Khanum F, Bawa AS. Nutritional, medicinal and industrial uses of sesame (Sesamum indicum L.) seeds – an overview. Agric Conspec Sci. 2010;75(4):159–68.
36. Abdel-Zaher AO, Salim SY, Assaf MH. Pharmacological screening of Ziziphus spina-christi fruits: antinociceptive and anti-inflammatory activities. J Ethnopharmacol. 2005;102(2):266–73. doi:10.1016/j.jep.2005.06.031
37. El Kamali HH, Khalid SA. The most common herbal remedies in central Sudan. Phytother Res. 1996;10(5):479–86. doi:10.1002/(SICI)1099-1573(199608)10:5<479::AID-PTR857>3.0.CO;2-I
38. Ghasemzadeh A, Jaafar HZE, Rahmat A. Antioxidant activities, total phenolics and flavonoids content in two varieties of Eruca sativa. J Med Plants Res. 2011;5(17):3891–6.
39. Fawzy GA, Al-Taweel AM, Perveen S, et al. Phytochemical and biological evaluation of Eruca sativa seeds. Saudi Pharm J. 2013;21(2):143–8. doi:10.1016/j.jsps.2012.04.002
40. Shah G, Shri R, Panchal V, Sharma N, Singh B, Mann AS. Scientific basis for the therapeutic use of Cymbopogon citratus Stapf (Lemon grass). J Adv Pharm Technol Res. 2011;2(1):3–8. doi:10.4103/2231-4040.79796
41. Ekpenyong CE, Akpan E, Daniel NE. Phytochemistry and toxicology of Cymbopogon citratus: a therapeutic review. J Med Food. 2015;18(5):610–16. doi:10.1089/jmf.2014.0107
42. McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res. 2006;20(8):619–33. doi:10.1002/ptr.1936
43. Mimica-Dukić N, Božin B. Mentha L. species (Lamiaceae) as promising sources of bioactive secondary metabolites. Curr Pharm Des. 2008;14(29):3141–50. doi:10.2174/138161208786404272
44. Ojieh GC, Adegor EC, Okolo PO. Physiochemical characteristics and fatty acid composition of Ricinus communis L. oil. J Appl Sci Environ Manage. 2012;16(1):85–8. doi:10.4314/jasem.v16i1.12
45. Salunkhe DK, Chavan JK. Ricinus communis L. (Castor). In: World oilseeds: chemistry, technology, and utilization. Springer; 1992. p. 457–68. doi:10.1007/978-1-4615-3346-1_14
46. El Ghazali GE, El Tohami MS, El Egami AA, Abdalla WS, Mohammed MG. Medicinal plants of the Sudan. Part IV. Khartoum: National Centre for Research; 1997.
47. Abdel-Fattah AFM, Matsumoto K, Watanabe H. Antinociceptive effects of Boswellia carterii extract in mice. J Ethnopharmacol. 2000;72(1–2):227–33. doi:10.1016/S0378-8741(00)00227-8
48. World Health Organization. WHO traditional medicine strategy 2014–2023. Geneva: WHO; 2013.
49. Grand View Research. Herbal cosmetics market size, share & trends analysis report 2023–2030. San Francisco: GVR; 2023.
50. El Kamali HH, El Khalifa KF. Traditional medicinal plants of Sudan: an overview of medicinal flora used in Sudanese ethnomedicine. J Ethnobiol Ethnomed. 2010;6:13. doi:10.1186/1746-4269-6-13
51. United Nations Development Programme (UNDP). Women’s empowerment and entrepreneurship in Africa. New York: UNDP; 2022.
52. Mukherjee PK, Maity N, Nema NK, Sarkar BK. Bioactive compounds from natural resources against skin aging. Phytomedicine. 2011;19(1):64–73. doi:10.1016/j.phymed.2011.10.003
53. El Hadek M, Cherkaoui A. Women, argan oil, and cooperative development in Morocco. J North Afr Stud. 2016;21(3):410–25. doi:10.1080/13629387.2015.1065041
54. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. doi:10.3389/fphar.2013.00177
55. World Trade Organization. Trade and standards in herbal and natural products. Geneva: WTO; 2020.
56. Mukherjee PK, Bahadur S, Chaudhary SK, Kar A, Mukherjee K. Value addition of botanicals for cosmeceuticals: a scientific overview. J Ethnopharmacol. 2018;211:188–93. doi:10.1016/j.jep.2017.09.030
57. Mukherjee PK, Harwansh RK, Bahadur S, Banerjee S, Kar A, Chanda J. Development of cosmeceuticals from botanicals. Drug Discov Today. 2022;27(2):636–43. doi:10.1016/j.drudis.2021.09.009
58. Heinrich M, Edwards S, Moerman DE, Leonti M. Ethnopharmacological field studies: a critical assessment of their conceptual basis and methods. J Ethnopharmacol. 2009;124(1):1–17. doi:10.1016/j.jep.2009.03.043
59. Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137(2):293–300. doi:10.1039/C1AN15605E
60. Prakash O, Rout PK, Chanotiya CS. Industrial utilization of medicinal and aromatic plants: challenges and opportunities. Ind Crops Prod. 2019;138:111473. doi:10.1016/j.indcrop.2019.111473
61. World Health Organization (WHO). Traditional medicine strategy 2014–2023. Geneva: WHO; 2013.
62. FAO. Non-wood forest products for rural income and sustainable forestry. Rome: Food and Agriculture Organization; 2020.
63. Aboyade OM, Beauclair R, Mbamalu ON, Puoane TR. Herbal medicines use among pregnant women in Africa: a systematic review. BMC Complement Altern Med. 2016;16:135. doi:10.1186/s12906-016-1162-0
64. Van Andel T, Carvalheiro LG. Why urban citizens in developing countries use traditional medicines: the case of Suriname. J Ethnopharmacol. 2013;146(3):842–52. doi:10.1016/j.jep.2013.02.040
65. Shackleton CM, Pandey AK. Positioning non-timber forest products on the development agenda: a case study of Southern Africa. For Policy Econ. 2014;38:65–73. doi:10.1016/j.forpol.2013.07.004

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.